CompletedInterventionalNot ApplicableLast updated Jan 7, 2025

ACT with NMOSD Patients and Caregivers Pilot Study

Acceptance and Commitment Therapy with Neuromyelitis Optica Spectrum Disorder Patient and Caregiver Pilot Study

Overview

ClinicalTrials.gov ID: NCT05840055
Lead Sponsor: Thomas Jefferson UniversityOTHER
Brief Summary: This study will examine the effectiveness of a neuromyelitis optics spectrum disorder (NMOSD) specific Acceptance and Commitment Therapy (ACT) intervention at reducing anxiety and depression in individuals with NMOSD and their caregivers/loved ones and improving overall health outcomes in individuals with NMOSD.
Study Type

Status

Study Record Dates

NCT06780709Recruiting

Impact of a Structured Wellness Behavioral Intervention on Quality of Life in NMOSD

NCT07239609Recruiting

ACT for Individuals With MNCD and Their Care Partners

NCT06897553Recruiting

ACT for Mental Health in Neurological Disorders

NCT02087813Withdrawn

Pilot Study of alpha1-antitrypsin to Treat Neuromyelitis Optica Relapses

NCT05749939Completed

Acceptance Commitment Therapy for Caregivers of People with Memory Loss

NCT03062579Completed

A Longitudinal Study of ACTEMRA® (Tocilizumab) as Monotherapy in Highly Active NMOSD